Please assess the completion status of the following clinical trial:

Trial Title: BVAIT: B-Vitamin Atherosclerosis Intervention Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female (postmenopausal)~* 40 years or older~* Fasting plasma homocysteine 8.5 micromoles per liter (µmol/L) or greater~Exclusion Criteria:~* Any clinical signs or symptoms of cardiovascular disease (CVD)~* Diabetes mellitus or fasting serum glucose 140 mg/dL or greater~* Triglyceride (TG) levels 500mg/dL or greater~* Serum creatinine greater than 1.6 mg/dL~* Uncontrolled hypertension (systolic blood pressure 160 mmHg or greater and/or diastolic blood pressure 100 mmHg or greater)~* Thyroid disease (untreated)~* Life threatening disease with prognosis less than 5 years~* Alcohol intake greater than 5 drinks per day (1 drink = 1 1/2 oz distilled spirits, 4 oz wine, or 12 oz beer) or substance abuse (intravenous drug use, cocaine use)

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).